Feltl & Co Downgrades Insulet Corporation (PODD) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Insulet Reports First Quarter 2015 Financial Results
April 30, 2015 4:01 PM EDTBILLERICA, MA -- (Marketwired) -- 04/30/15 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod Insulin Management System, today announced financial results for the three months ended March 31, 2015.
First Quarter Highlights and Recent Developments:
First quarter financial results: U.S. OmniPod revenue in-line with Company's expectations. Drug Delivery and International shipments planned for the first quarter now expected to be realized during remainder of 2015. Strengthened senior leadership team with appointment of highly-experienced Chief Financial Officer. Previously announced: First... More